Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MeMed Secures $93M Financing To Commercialize Diagnostics Platform

Jan 10 2022

• By Barnaby Pickering

MeMeds Key testing platform

Related Content

MeMed’s Mission: Pressing Its Fingerprint Against AMR

Sep 22 2021

Exec Chat: MeMed Improves Diagnostics To Combat Antimicrobial resistance

Oct 19 2021

First Test That Predicts Severe Outcomes In COVID-19 Patients Receives CE Mark

Jul 27 2021

Minute Insight: MeMed Announces Viral/Bacterial Infection Differentiation Results, Commercial Partnership

Dec 01 2021

Related Companies

MeMed

Thermo Fisher Scientific

Additional Topics

Financing Coronavirus COVID-19 Deals Commercial Innovation Diagnostics Medical Device

More from Diagnostics

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window